Purchase Order 75N93020P00562

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Tecan Genomics, Inc. for $35,595.00 on February 9, 2021, for Universal Plus mRNA-SEQ Library Preparation Kits (quantity 5). Performance occurs at Tecan Genomics' facility in Redwood City, California. The order is firm fixed price with no small business set-aside. Ultimate completion is scheduled for February 16, 2021.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Tecan Genomics, Inc. on September 4, 2020, for a KT Ovation Solo RNA-Seq System Mouse 96 unit at $20,097.00 firm fixed price. Performance occurs in Redwood City, California, with an ultimate completion date of October 3, 2020.</p>

The National Institute of Allergy and Infectious Diseases awarded a purchase order to 10X Genomics, Inc. on July 1, 2020, with a ceiling value of $22,817.50 for genomic analysis equipment and reagents. The order was a firm fixed-price acquisition without set-aside designation. Performance is located in Bethesda, Maryland, with an ultimate completion date of July 31, 2020. The purchase order procures specialized genomic research consumables and instruments, including single-cell analysis kits and...

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Life Technologies Corporation for $20,170.38 on November 19, 2020, for laboratory consumables and equipment supplies. The order covers Big Dye Terminator V3 kits, microamp clear adhesive seals, microamp 96-well reaction plates, HIDI formamide, microamp film and plates, and related reagents. Place of performance is Carlsbad, California. The ultimate completion date was December 3, 2020. The purchase order was...

This firm fixed price purchase order for $23,259.00 was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Tecan Genomics, Inc., a Switzerland-based manufacturer and distributor of automation and detection solutions for life science laboratories. The award is for the provision of 4 units of Universal Plus mRNA-Seq Kits, with a completion date of January 3, 2020. There was no set-aside...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Illumina, Inc. for sequencing kits valued at $19,072.05, with an award date of April 13, 2021 and completion date of May 12, 2021. Performance occurs in San Diego, California. The order is firm fixed price with no set-aside designation.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Illumina, Inc. for $14,688.00 for an Illumina reagent kit, with an award date of August 12, 2020 and completion date of September 11, 2020. The order is firm fixed price with no set-aside. Place of performance is San Diego, California.</p>

Tecan Genomics Inc. has been awarded a firm fixed-price purchase order valued at fifteen thousand seven hundred twenty-three dollars by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide RNA sequencing services. Specifically, the prime contractor will deliver universal plus total RNA sequencing with NuQuant human any deplete analysis for the NIH's infectious disease programs. Performance will take place in Redwood City, California over a four...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Illumina, Inc. for $14,688.00 on August 14, 2020, for NovaSeq 6000 S4 reagent kits (300 cycles) in support of COVID-19 research. Place of performance is San Diego, California. The order carries firm fixed-price pricing with an ultimate completion date of September 4, 2020.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to 10X Genomics, Inc. for $11,389.00 on December 31, 2020, for Chromium Chip A and B Single Cell Kits (48 reactions each) in support of COVID-19 research. The order carries no set-aside designation and is priced on a firm fixed price basis. Place of performance is Pleasanton, California. The ultimate completion date is February 1, 2021.</p>